Publication:
Successful retreatment with erlotinib after erlotinib-related interstitial lung disease.

dc.contributor.authorTurk, HACI MEHMET
dc.contributor.authorAdli, Mustafa
dc.contributor.authorSimsek, Melih
dc.contributor.authorAliyev, Altay
dc.contributor.authorBesiroglu, Mehmet
dc.contributor.institutionauthorTÜRK, HACI MEHMET
dc.date.accessioned2021-08-03T20:59:14Z
dc.date.available2021-08-03T20:59:14Z
dc.date.issued2021-06-04T00:00:00Z
dc.identifier.citationTurk H. M. , Adli M., Simsek M., Aliyev A., Besiroglu M., -Successful retreatment with erlotinib after erlotinib-related interstitial lung disease.-, Tumori, 2021
dc.identifier.doi10.1177/03008916211020097
dc.identifier.pubmed34082639
dc.identifier.scopus85107262537
dc.identifier.urihttp://hdl.handle.net/20.500.12645/29108
dc.titleSuccessful retreatment with erlotinib after erlotinib-related interstitial lung disease.
dc.typeArticle
dspace.entity.typePublication
local.avesis.id51ae3f56-2941-497c-bc32-e0af80c0fced
local.publication.goal03 - Sağlık ve Kaliteli Yaşam
local.publication.isinternational1
relation.isAuthorOfPublication1b3a1540-7e57-405d-8a9d-f926d17dcc29
relation.isAuthorOfPublication.latestForDiscovery1b3a1540-7e57-405d-8a9d-f926d17dcc29
relation.isGoalOfPublication9c198c48-b603-4e2f-8366-04edcfc1224c
relation.isGoalOfPublication.latestForDiscovery9c198c48-b603-4e2f-8366-04edcfc1224c
Files